Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Calcitriol | 31 | 2016 | 129 | 8.110 |
Why?
|
Vitamin D | 20 | 2016 | 261 | 4.410 |
Why?
|
Renin-Angiotensin System | 18 | 2015 | 133 | 4.200 |
Why?
|
Calcitriol | 13 | 2013 | 174 | 3.050 |
Why?
|
Diabetic Nephropathies | 9 | 2017 | 245 | 2.230 |
Why?
|
Signal Transduction | 16 | 2017 | 3226 | 1.980 |
Why?
|
Renin | 11 | 2012 | 78 | 1.970 |
Why?
|
Gene Expression Regulation | 17 | 2015 | 1903 | 1.760 |
Why?
|
Podocytes | 6 | 2013 | 30 | 1.560 |
Why?
|
NF-kappa B | 9 | 2017 | 441 | 1.450 |
Why?
|
Intestinal Mucosa | 7 | 2015 | 788 | 1.440 |
Why?
|
Vitamins | 5 | 2010 | 81 | 1.430 |
Why?
|
Mice | 42 | 2017 | 11279 | 1.310 |
Why?
|
Epithelial Cells | 8 | 2015 | 662 | 1.200 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 4 | 2010 | 90 | 1.080 |
Why?
|
Animals | 51 | 2017 | 26469 | 1.080 |
Why?
|
Losartan | 7 | 2010 | 42 | 1.060 |
Why?
|
Hyperglycemia | 3 | 2017 | 176 | 1.020 |
Why?
|
Kidney | 8 | 2017 | 1236 | 1.010 |
Why?
|
Inflammation | 7 | 2015 | 910 | 1.000 |
Why?
|
Kidney Diseases | 4 | 2013 | 418 | 0.960 |
Why?
|
Mesangial Cells | 2 | 2017 | 7 | 0.960 |
Why?
|
Mice, Knockout | 16 | 2015 | 1910 | 0.950 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2017 | 190 | 0.950 |
Why?
|
Colitis | 6 | 2015 | 235 | 0.930 |
Why?
|
Epigenesis, Genetic | 2 | 2017 | 468 | 0.900 |
Why?
|
MicroRNAs | 5 | 2016 | 534 | 0.900 |
Why?
|
Cyclic AMP | 2 | 2017 | 273 | 0.850 |
Why?
|
Ergocalciferols | 3 | 2010 | 38 | 0.800 |
Why?
|
Glucose | 2 | 2017 | 637 | 0.760 |
Why?
|
Vitamin D Deficiency | 5 | 2013 | 103 | 0.760 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2015 | 543 | 0.700 |
Why?
|
Promoter Regions, Genetic | 8 | 2017 | 933 | 0.700 |
Why?
|
Energy Metabolism | 2 | 2011 | 270 | 0.650 |
Why?
|
ATP Citrate (pro-S)-Lyase | 1 | 2017 | 3 | 0.620 |
Why?
|
Histones | 2 | 2017 | 305 | 0.610 |
Why?
|
Macrophages | 4 | 2013 | 553 | 0.600 |
Why?
|
Calcium | 8 | 2016 | 1147 | 0.600 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 66 | 0.600 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 2 | 2013 | 19 | 0.580 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 106 | 0.580 |
Why?
|
Homeostasis | 6 | 2015 | 407 | 0.560 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2015 | 6 | 0.560 |
Why?
|
Albuminuria | 3 | 2016 | 153 | 0.560 |
Why?
|
S100 Calcium Binding Protein G | 2 | 2005 | 22 | 0.520 |
Why?
|
Adipocytes | 3 | 2011 | 152 | 0.520 |
Why?
|
Mice, Inbred C57BL | 11 | 2015 | 3077 | 0.520 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 826 | 0.520 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 368 | 0.510 |
Why?
|
Interleukin-18 | 2 | 2006 | 26 | 0.510 |
Why?
|
Interleukin-10 | 1 | 2015 | 149 | 0.500 |
Why?
|
Pulmonary Fibrosis | 1 | 2015 | 123 | 0.490 |
Why?
|
Receptor, TIE-2 | 1 | 2013 | 15 | 0.480 |
Why?
|
Angiopoietin-2 | 1 | 2013 | 15 | 0.480 |
Why?
|
Keratinocytes | 2 | 2006 | 143 | 0.470 |
Why?
|
Kidney Glomerulus | 2 | 2013 | 122 | 0.460 |
Why?
|
Acute Lung Injury | 1 | 2013 | 60 | 0.450 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 191 | 0.440 |
Why?
|
Angiotensin II | 5 | 2015 | 94 | 0.440 |
Why?
|
Atherosclerosis | 2 | 2013 | 243 | 0.440 |
Why?
|
Angiotensinogen | 2 | 2009 | 8 | 0.440 |
Why?
|
Mice, Transgenic | 5 | 2015 | 1533 | 0.430 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 91 | 0.430 |
Why?
|
Receptors, LDL | 1 | 2012 | 53 | 0.430 |
Why?
|
Vitamin D Response Element | 1 | 2011 | 1 | 0.420 |
Why?
|
Blood Pressure | 3 | 2007 | 1141 | 0.410 |
Why?
|
Juxtaglomerular Apparatus | 2 | 2008 | 2 | 0.410 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 45 | 0.390 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2010 | 36 | 0.390 |
Why?
|
Fatty Acids | 1 | 2011 | 129 | 0.390 |
Why?
|
Inflammation Mediators | 4 | 2013 | 154 | 0.390 |
Why?
|
Antihypertensive Agents | 4 | 2012 | 520 | 0.390 |
Why?
|
Colon | 4 | 2015 | 495 | 0.380 |
Why?
|
Membrane Proteins | 3 | 2012 | 1194 | 0.370 |
Why?
|
Immunity, Innate | 1 | 2013 | 403 | 0.370 |
Why?
|
Fibroblasts | 3 | 2010 | 729 | 0.360 |
Why?
|
Hair Follicle | 2 | 2016 | 26 | 0.350 |
Why?
|
Alopecia | 2 | 2016 | 34 | 0.350 |
Why?
|
Protective Agents | 1 | 2009 | 32 | 0.350 |
Why?
|
Up-Regulation | 5 | 2017 | 710 | 0.340 |
Why?
|
Polyuria | 1 | 2008 | 8 | 0.340 |
Why?
|
Thirst | 1 | 2008 | 19 | 0.340 |
Why?
|
Hypertension | 5 | 2015 | 1137 | 0.330 |
Why?
|
Humans | 34 | 2016 | 86102 | 0.330 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2015 | 683 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 349 | 0.320 |
Why?
|
Mitochondrial Proteins | 1 | 2009 | 123 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2016 | 1366 | 0.310 |
Why?
|
RNA, Messenger | 8 | 2014 | 1974 | 0.310 |
Why?
|
Fibrosis | 3 | 2017 | 201 | 0.310 |
Why?
|
Models, Biological | 5 | 2013 | 1746 | 0.300 |
Why?
|
Cells, Cultured | 7 | 2016 | 2802 | 0.300 |
Why?
|
Ion Channels | 1 | 2009 | 245 | 0.300 |
Why?
|
Lipopolysaccharides | 3 | 2013 | 285 | 0.300 |
Why?
|
Captopril | 2 | 2004 | 20 | 0.300 |
Why?
|
Enzyme Inhibitors | 3 | 2009 | 632 | 0.290 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2006 | 12 | 0.280 |
Why?
|
Sialoglycoproteins | 1 | 2006 | 31 | 0.280 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 53 | 0.280 |
Why?
|
Interleukin-1 | 1 | 2006 | 71 | 0.280 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 231 | 0.270 |
Why?
|
Calcium, Dietary | 1 | 2005 | 63 | 0.260 |
Why?
|
Cell Line | 5 | 2013 | 2462 | 0.260 |
Why?
|
Obesity | 1 | 2011 | 959 | 0.250 |
Why?
|
Acetylation | 2 | 2017 | 121 | 0.250 |
Why?
|
Cell Line, Transformed | 2 | 2017 | 153 | 0.250 |
Why?
|
Connective Tissue Growth Factor | 2 | 2017 | 14 | 0.250 |
Why?
|
Sulfates | 1 | 2004 | 56 | 0.250 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2017 | 75 | 0.250 |
Why?
|
Disease Progression | 3 | 2015 | 1526 | 0.250 |
Why?
|
Cardiomegaly | 1 | 2004 | 111 | 0.240 |
Why?
|
Gene Expression | 6 | 2009 | 1279 | 0.240 |
Why?
|
Cation Transport Proteins | 1 | 2004 | 64 | 0.240 |
Why?
|
Symporters | 1 | 2004 | 104 | 0.240 |
Why?
|
Apoptosis | 4 | 2015 | 1678 | 0.240 |
Why?
|
Fibronectins | 2 | 2017 | 93 | 0.240 |
Why?
|
Time Factors | 5 | 2017 | 5198 | 0.230 |
Why?
|
RNA Interference | 3 | 2017 | 368 | 0.230 |
Why?
|
Dextran Sulfate | 3 | 2014 | 68 | 0.230 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2003 | 80 | 0.220 |
Why?
|
Neoplasm Proteins | 1 | 2006 | 532 | 0.220 |
Why?
|
Mice, Inbred DBA | 2 | 2012 | 148 | 0.200 |
Why?
|
Fumarates | 2 | 2012 | 26 | 0.190 |
Why?
|
Amides | 2 | 2012 | 59 | 0.180 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 874 | 0.180 |
Why?
|
HCT116 Cells | 3 | 2015 | 150 | 0.180 |
Why?
|
Tight Junctions | 2 | 2013 | 144 | 0.180 |
Why?
|
Phosphorylation | 3 | 2017 | 1101 | 0.180 |
Why?
|
Cytokines | 3 | 2015 | 775 | 0.180 |
Why?
|
Oxidation-Reduction | 2 | 2011 | 373 | 0.170 |
Why?
|
Disease Models, Animal | 4 | 2010 | 2225 | 0.170 |
Why?
|
DNA, Complementary | 3 | 2004 | 392 | 0.170 |
Why?
|
Drug Synergism | 2 | 2010 | 303 | 0.170 |
Why?
|
Sodium-Hydrogen Exchangers | 2 | 2009 | 79 | 0.170 |
Why?
|
Receptor, Angiotensin, Type 1 | 3 | 2009 | 21 | 0.160 |
Why?
|
Cell Nucleus | 3 | 2015 | 578 | 0.160 |
Why?
|
Acetyl Coenzyme A | 1 | 2017 | 7 | 0.150 |
Why?
|
Mice, Mutant Strains | 2 | 2011 | 228 | 0.150 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2017 | 16 | 0.150 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 1378 | 0.150 |
Why?
|
Collagen Type IV | 1 | 2017 | 24 | 0.150 |
Why?
|
Trinitrobenzenesulfonic Acid | 2 | 2015 | 16 | 0.150 |
Why?
|
Citric Acid | 1 | 2017 | 38 | 0.150 |
Why?
|
Enzyme Activation | 2 | 2013 | 692 | 0.150 |
Why?
|
Drug Therapy, Combination | 2 | 2010 | 893 | 0.150 |
Why?
|
Colonic Neoplasms | 2 | 2014 | 553 | 0.150 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2017 | 87 | 0.150 |
Why?
|
Thioctic Acid | 1 | 2016 | 1 | 0.140 |
Why?
|
Finasteride | 1 | 2016 | 7 | 0.140 |
Why?
|
Carnitine | 1 | 2016 | 14 | 0.140 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2016 | 7 | 0.140 |
Why?
|
Salts | 2 | 2008 | 16 | 0.140 |
Why?
|
Sterols | 1 | 2016 | 16 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 2 | 2016 | 196 | 0.140 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2015 | 41 | 0.140 |
Why?
|
Endocrine System | 2 | 2015 | 17 | 0.140 |
Why?
|
Parathyroid Hormone | 2 | 2008 | 218 | 0.130 |
Why?
|
Androgens | 1 | 2016 | 164 | 0.130 |
Why?
|
Transfection | 1 | 2017 | 894 | 0.130 |
Why?
|
Calbindins | 2 | 2005 | 19 | 0.130 |
Why?
|
Peptide Hormones | 1 | 2015 | 29 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 74 | 0.130 |
Why?
|
DNA Primers | 3 | 2008 | 542 | 0.130 |
Why?
|
Prostatic Hyperplasia | 1 | 2016 | 77 | 0.130 |
Why?
|
Phytotherapy | 1 | 2016 | 132 | 0.130 |
Why?
|
Base Sequence | 2 | 2010 | 2327 | 0.120 |
Why?
|
Male | 10 | 2016 | 40834 | 0.120 |
Why?
|
Down-Regulation | 2 | 2016 | 503 | 0.120 |
Why?
|
Vitamin D3 24-Hydroxylase | 1 | 2013 | 6 | 0.120 |
Why?
|
Steroid Hydroxylases | 1 | 2013 | 14 | 0.120 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2013 | 121 | 0.120 |
Why?
|
Suppressor of Cytokine Signaling 1 Protein | 1 | 2013 | 6 | 0.120 |
Why?
|
Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2013 | 23 | 0.120 |
Why?
|
Water-Electrolyte Balance | 2 | 2003 | 66 | 0.120 |
Why?
|
Capillary Permeability | 1 | 2013 | 130 | 0.110 |
Why?
|
Bone and Bones | 2 | 2004 | 264 | 0.110 |
Why?
|
Caco-2 Cells | 2 | 2015 | 122 | 0.110 |
Why?
|
Permeability | 2 | 2015 | 133 | 0.110 |
Why?
|
Feedback, Physiological | 1 | 2013 | 62 | 0.110 |
Why?
|
Proteinuria | 1 | 2013 | 107 | 0.110 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2013 | 70 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 199 | 0.110 |
Why?
|
Wnt Signaling Pathway | 1 | 2013 | 89 | 0.110 |
Why?
|
Gene Deletion | 1 | 2013 | 328 | 0.110 |
Why?
|
Transcriptional Activation | 1 | 2013 | 279 | 0.110 |
Why?
|
Nuclear Proteins | 1 | 2017 | 692 | 0.110 |
Why?
|
Rats | 3 | 2015 | 3982 | 0.110 |
Why?
|
Sodium-Hydrogen Exchanger 3 | 2 | 2009 | 32 | 0.110 |
Why?
|
Phenotype | 2 | 2011 | 2369 | 0.100 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2011 | 1 | 0.100 |
Why?
|
Lipolysis | 1 | 2011 | 22 | 0.100 |
Why?
|
Retinoid X Receptors | 1 | 2011 | 39 | 0.100 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2011 | 26 | 0.100 |
Why?
|
Biological Transport, Active | 1 | 2011 | 101 | 0.100 |
Why?
|
Intestines | 1 | 2015 | 407 | 0.100 |
Why?
|
Cell Adhesion Molecules | 1 | 2012 | 163 | 0.100 |
Why?
|
Myocardial Infarction | 1 | 2015 | 372 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 279 | 0.100 |
Why?
|
Hypersensitivity | 1 | 2013 | 152 | 0.100 |
Why?
|
RNA Polymerase II | 1 | 2011 | 55 | 0.100 |
Why?
|
Thermogenesis | 1 | 2011 | 34 | 0.100 |
Why?
|
Bone Marrow Cells | 1 | 2012 | 252 | 0.100 |
Why?
|
Kidney Tubules | 1 | 2011 | 94 | 0.100 |
Why?
|
Organ Specificity | 1 | 2011 | 257 | 0.100 |
Why?
|
Aorta | 1 | 2012 | 280 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2013 | 424 | 0.100 |
Why?
|
Lipids | 1 | 2012 | 269 | 0.100 |
Why?
|
Angiotensin I | 1 | 2010 | 6 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 377 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2011 | 193 | 0.090 |
Why?
|
Blood Urea Nitrogen | 1 | 2010 | 34 | 0.090 |
Why?
|
Receptors, Leptin | 1 | 2010 | 32 | 0.090 |
Why?
|
Locomotion | 1 | 2011 | 130 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 47 | 0.090 |
Why?
|
Cholesterol | 1 | 2012 | 356 | 0.090 |
Why?
|
Collagen Type I | 1 | 2010 | 62 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2013 | 354 | 0.090 |
Why?
|
Female | 8 | 2016 | 44359 | 0.090 |
Why?
|
Glomerular Basement Membrane | 1 | 2009 | 4 | 0.090 |
Why?
|
Risk | 1 | 2011 | 673 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2010 | 123 | 0.090 |
Why?
|
Uncoupling Protein 3 | 1 | 2009 | 9 | 0.090 |
Why?
|
Uncoupling Protein 2 | 1 | 2009 | 11 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2011 | 615 | 0.090 |
Why?
|
RNA | 2 | 2004 | 559 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2008 | 1439 | 0.090 |
Why?
|
Uncoupling Protein 1 | 1 | 2009 | 35 | 0.090 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 924 | 0.090 |
Why?
|
RNA, Small Interfering | 2 | 2008 | 547 | 0.090 |
Why?
|
Prevalence | 1 | 2013 | 1238 | 0.090 |
Why?
|
Creatinine | 1 | 2010 | 337 | 0.080 |
Why?
|
Streptozocin | 1 | 2008 | 54 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2008 | 68 | 0.080 |
Why?
|
Drug Interactions | 1 | 2009 | 248 | 0.080 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2008 | 7 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 534 | 0.080 |
Why?
|
Transcription, Genetic | 1 | 2013 | 1127 | 0.080 |
Why?
|
Drug Combinations | 1 | 2008 | 222 | 0.080 |
Why?
|
Oxygen Consumption | 1 | 2009 | 239 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2010 | 297 | 0.080 |
Why?
|
Ulcer | 1 | 2007 | 35 | 0.080 |
Why?
|
Sodium | 1 | 2009 | 340 | 0.080 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2007 | 19 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2009 | 196 | 0.080 |
Why?
|
Electric Impedance | 1 | 2007 | 104 | 0.080 |
Why?
|
Cholecalciferol | 1 | 2007 | 35 | 0.080 |
Why?
|
Response Elements | 1 | 2007 | 62 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2012 | 722 | 0.080 |
Why?
|
Lung | 1 | 2013 | 1165 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2016 | 1794 | 0.080 |
Why?
|
Drug Design | 1 | 2007 | 124 | 0.070 |
Why?
|
Molecular Structure | 1 | 2007 | 287 | 0.070 |
Why?
|
Adenoma, Oxyphilic | 1 | 2006 | 28 | 0.070 |
Why?
|
Phorbol Esters | 1 | 2006 | 22 | 0.070 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2006 | 11 | 0.070 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2006 | 41 | 0.070 |
Why?
|
Ligands | 1 | 2007 | 433 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 286 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 565 | 0.070 |
Why?
|
Crohn Disease | 1 | 2012 | 729 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2012 | 1190 | 0.070 |
Why?
|
RNA Stability | 1 | 2006 | 86 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 509 | 0.070 |
Why?
|
Colitis, Ulcerative | 1 | 2012 | 707 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2006 | 254 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 734 | 0.070 |
Why?
|
Antibodies | 1 | 2007 | 349 | 0.070 |
Why?
|
Pregnancy | 1 | 2012 | 2882 | 0.070 |
Why?
|
Wound Healing | 1 | 2007 | 342 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 1958 | 0.070 |
Why?
|
Rickets | 1 | 2004 | 5 | 0.060 |
Why?
|
Calbindin 1 | 1 | 2004 | 11 | 0.060 |
Why?
|
Duodenum | 1 | 2005 | 99 | 0.060 |
Why?
|
Atrial Natriuretic Factor | 1 | 2004 | 39 | 0.060 |
Why?
|
Chromatin | 1 | 2007 | 366 | 0.060 |
Why?
|
Parathyroid Glands | 1 | 2004 | 74 | 0.060 |
Why?
|
Blotting, Northern | 1 | 2004 | 256 | 0.060 |
Why?
|
Glutathione | 1 | 2004 | 103 | 0.060 |
Why?
|
Cell Movement | 1 | 2007 | 754 | 0.060 |
Why?
|
Peptides | 1 | 2007 | 639 | 0.060 |
Why?
|
Weight Gain | 1 | 2004 | 123 | 0.060 |
Why?
|
Proteoglycans | 1 | 2004 | 121 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 122 | 0.060 |
Why?
|
Eating | 1 | 2004 | 166 | 0.060 |
Why?
|
Biomarkers | 1 | 2010 | 1707 | 0.060 |
Why?
|
Submandibular Gland | 1 | 2003 | 16 | 0.060 |
Why?
|
Aldosterone | 1 | 2003 | 65 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2004 | 231 | 0.060 |
Why?
|
Sodium, Dietary | 1 | 2002 | 13 | 0.050 |
Why?
|
Calcium Signaling | 1 | 2003 | 129 | 0.050 |
Why?
|
Drinking Behavior | 1 | 2002 | 13 | 0.050 |
Why?
|
Keratin-14 | 1 | 2002 | 5 | 0.050 |
Why?
|
Hypocalcemia | 1 | 2002 | 41 | 0.050 |
Why?
|
Keratins | 1 | 2002 | 63 | 0.050 |
Why?
|
Cloning, Molecular | 1 | 2003 | 646 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2006 | 421 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2003 | 418 | 0.050 |
Why?
|
Models, Genetic | 1 | 2007 | 926 | 0.050 |
Why?
|
Neuropeptides | 1 | 2002 | 112 | 0.050 |
Why?
|
Myocytes, Cardiac | 1 | 2004 | 275 | 0.050 |
Why?
|
Transgenes | 1 | 2002 | 180 | 0.050 |
Why?
|
Protein Kinase C | 1 | 2002 | 270 | 0.050 |
Why?
|
DNA | 1 | 2007 | 1291 | 0.050 |
Why?
|
Water | 1 | 2003 | 274 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 684 | 0.050 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 303 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2006 | 616 | 0.050 |
Why?
|
In Vitro Techniques | 1 | 2002 | 987 | 0.050 |
Why?
|
Mutation | 1 | 2011 | 3948 | 0.050 |
Why?
|
Blotting, Western | 2 | 2014 | 779 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2007 | 1160 | 0.050 |
Why?
|
Trans-Activators | 1 | 2002 | 429 | 0.040 |
Why?
|
Skin | 1 | 2002 | 554 | 0.040 |
Why?
|
Liver | 1 | 2004 | 1229 | 0.040 |
Why?
|
Treatment Outcome | 1 | 2011 | 7933 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2002 | 1752 | 0.040 |
Why?
|
Chemoprevention | 1 | 2016 | 91 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2015 | 93 | 0.030 |
Why?
|
Caspase 3 | 1 | 2015 | 159 | 0.030 |
Why?
|
HT29 Cells | 1 | 2014 | 49 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 47 | 0.030 |
Why?
|
Adenoma | 1 | 2016 | 233 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 261 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2015 | 1040 | 0.030 |
Why?
|
Protein Transport | 1 | 2015 | 410 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 270 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 321 | 0.030 |
Why?
|
Cell Cycle | 1 | 2015 | 502 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2014 | 676 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2014 | 1796 | 0.020 |
Why?
|
Microvilli | 1 | 2009 | 42 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2015 | 1571 | 0.020 |
Why?
|
Ion Transport | 1 | 2009 | 81 | 0.020 |
Why?
|
Exocytosis | 1 | 2009 | 108 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2009 | 266 | 0.020 |
Why?
|
Cell Polarity | 1 | 2009 | 114 | 0.020 |
Why?
|
Azo Compounds | 1 | 2008 | 13 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 32 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 92 | 0.020 |
Why?
|
Luciferases | 1 | 2008 | 118 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2007 | 23 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2007 | 78 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2007 | 99 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 115 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 120 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2007 | 192 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2006 | 124 | 0.020 |
Why?
|
Cell Division | 1 | 2007 | 696 | 0.020 |
Why?
|
Aged | 2 | 2016 | 18331 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 337 | 0.020 |
Why?
|
Middle Aged | 2 | 2016 | 24935 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2006 | 1562 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 2419 | 0.010 |
Why?
|
Biomarkers, Tumor | 1 | 2006 | 1459 | 0.010 |
Why?
|
Adult | 1 | 2016 | 25559 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2006 | 6481 | 0.010 |
Why?
|